COL4A3/COL4A4 Mutations Link Familial Hematuria and Focal Segmental Glomerulosclerosis. Glomerular Epithelium Destruction via Basement Membrane Thinning?

REFERENCES

• Mundel P., Shankland S. Podocyte biology and response to injury. J. Am. Soc. Nephrol. 2002; 13: 3005–3015
   PubMed Web of Science ®Google Scholar
• Kretzler K. Regulation of adhesive interaction between podocytes and glomerular basement membrane. Microsc. Res. Tech. 2002; 57: 247–253
   PubMed Web of Science ®Google Scholar
• Kaplan J.M., Kim S.H., North K.N., Rennke H., Correia L.A., Tong H.Q., Mathis B.J., Rodriguez-Perez, JC, Allen P.G., Beggs A.H., et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat. Genet. 2000; 24: 251–256
   PubMed Web of Science ®Google Scholar
• Weins A., Kenlan P., Herbert S., Le T.C., Villegas I., Kaplan B.S., Appel G.B., Pollak M.R. Mutational and biological analysis of alpha-actinin-4 in focal segmental glomerulosclerosis. J. Am. Soc. Nephrol. 2005; 16: 3694–3701
   PubMed Web of Science ®Google Scholar
• Winn M.P., Conlon P.J., Lynn K.L., Farrington M.K., Creazzo T., Hawkins A.F., Daskalakis N., Kwan S.Y., Ebersviller S., Burchette J.L., et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 2005; 308: 1801–1804
   PubMed Web of Science ®Google Scholar
• Reiser J., Polu K.R., Moller C.C., Kenlan P., Altintas M.M., Wei C., Faul C., Herbert S., Villegas I., Avila-Casado C., et al. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat. Genet. 2005; 37: 739–744
   PubMed Web of Science ®Google Scholar
• Kim J.M., Wu H., Green G., Winkler C.A., Kopp J.B., Miner J.H., Unanue E.R., Shaw A.S. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 2003; 300: 1298–1300
   PubMed Web of Science ®Google Scholar
• Boute N., Gribouval O., Roselli S., Benessy F., Lee H., Fuchshuber A., Dahan K., Gubler M.C., Niaudet P., Antignac C. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat. Genet. 2000; 24: 349–354
   PubMed Web of Science ®Google Scholar
• Winn M.P., Conlon P.J., Lynn K.L., Howell D.N., Gross D.A., Rogala A.R., Smith A.H., Graham F.l., Bembe M., Quarles L.D., et al. Clinical and genetic heterogenity in familial focal segmental glomerulosclerosis. Kidney Int. 1999; 55: 1241–1246
   PubMed Web of Science ®Google Scholar
• Conlon P.J., Butterly D., Albers F., Rodby R., Gunnels J.C., Howell D.N. Clinical and pathological features of familial focal segmental glomerulosclerosis. Am. J. Kidney Dis. 1995; 26: 34–40
   PubMed Web of Science ®Google Scholar
• Wang Y.Y., Savige J. The epidemiology of thin basement membrane nephropathy. Semin. Nephrol. 2005; 25: 136–139
   PubMed Web of Science ®Google Scholar
• Lemmink H.H., Nillesen W.N., Mochizuki T., Schroder C.H., Brunner H.G., van Oost B.A., Monnens L.A., Smeets H.J. Benign familial. hematuria due to mutation of the type IV collagen α4 gene. J. Clin. Invest 1996; 98: 1114–1118
   PubMed Web of Science ®Google Scholar
• Buzza M., Wang Y.Y., Dagher H., Babon J.J., Cotton R.G., Powell H., Dowling J., Savige J. COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome. Kidney Int. 2001; 60: 480–483
   PubMed Web of Science ®Google Scholar
• Ozen S., Ertoy D., Heidet L., Cohen-Solal L., Ozen H., Besbas N., Bakkaoglu A., Antignac C. Benign familial hematuria associated with a novel COL4A4 mutation. Pediatr. Nephrol. 2001; 16: 874–877
   PubMed Web of Science ®Google Scholar
• Badenas C., Praga M., Tazon B., Heidet L., Arrondel C., Armengol A., Andres A., Morales E., Camacho JA., Lens X., et al. Mutations in the COL4A4 and COL4A3 genes cause familial benign hematuria. J. Am. Soc. Nephrol. 2002; 13: 1248–1254
   PubMed Web of Science ®Google Scholar
• Longo I., Porcedda P., Mari F., Giachino D., Meloni I., Deplano C., Brusco A., Bosio M., Massella L., Lavoratti G., et al. COL4A3/COL4A4 mutations: from benign familial hematuria to autosomal dominant or recessive Alport syndrome. Kidney Int. 2002; 61: 1947–1956
   PubMed Web of Science ®Google Scholar
• Buzza M., Dagher H., Wang Y.Y., Wilson D., Babon J.J., Cotton R.G., Savige J. Mutations in the COL4A4 gene in thin basement membrane disease. Kidney Int. 2003; 63: 447–453
   PubMed Web of Science ®Google Scholar
• Gross O., Netzer K.O., Lambrecht R., Seibold S., Weber M. Novel COL4A4 splice defect and in-frame deletion in a large consanguine family as a genetic link between benign familial haematuria and autosomal Alport syndrome. Nephrol. Dial. Transplant. 2003; 18: 1122–1127
   PubMed Web of Science ®Google Scholar
• Tazon Vega B., Badenas C., Ars E., Lens X., Mila M., Darnell A., Torra R. Autosomal recessive Alport's syndrome and benign familial hematuria are collagen type IV diseases. Am. J. Kidney Dis. 2003; 42: 952–959
   PubMed Web of Science ®Google Scholar
• Wang Y.Y., Rana K., Tonna S., Llin T., Sin L., Savige J. COL4A3 mutations and their clinical consequences in thin basement membrane nephropathy (TBMN). Kidney Int. 2004; 65: 786–790
   PubMed Web of Science ®Google Scholar
• Rana K., Tonna S., Wang Y.Y., Sin L., Lin T., Shaw E., Mookerjee I., Savige J. Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases. Pediatr. Nephrol. 2007; 22: 652–657
   PubMed Web of Science ®Google Scholar
• Slajpah M., Gorinsek B., Berginc G., Vizjak A., Ferluga D., Hvala A., Meglic A., Jaksa I., Furlan P., Gregoric A., et al. Sixteen novel mutations identified in COL4A3, COL4A4, and COL4A5 genes in Slovenian families with Alport syndrome and benign familial hematuria. Kidney Int. 2007; 71: 1287–1295
   PubMed Web of Science ®Google Scholar
• Voskarides K., Damianou L., Neocleous V., Zouvani I., Christodoulidou S., Hadjiconstantinou V., Ioannou K., Athanasiou Y., Patsias C., Alexopoulos E., et al. COL4A3/COL4A4 mutations in families with thin basement membrane nephropathy that is associated with focal segmental glomerulosclerosis and chronic or end-stage renal failure. J. Am. Soc. Nephrol. 2007; 18: 3004–3016
   PubMed Web of Science ®Google Scholar
• Kadler K.E., Baldock C., Bella J., Boot-Handford R.P. Collagens at a glance. J. Cell. Sci. 2007; 120: 1955–1958
   PubMed Web of Science ®Google Scholar
• Prockop D.J., Kivirikko K.I. Collagens molecular biology, diseases, and potentials for therapy. Annu. Rev. Biochem. 1995; 64: 403–434
   PubMed Web of Science ®Google Scholar
• Alberts B., Johnson A., Lewis J., Raff M., Roberts K., Walter P. Molecular Biology of the Cell. V. Cells in Their Social Context, 19. Cell Junctions, Cell Adhesion, and the Extracellular Matrix4th ed., , et al. New York: Garland Science, Taylor & Francis Group. 2002
   Google Scholar
• Hudson B.G., Tryggvason K., Sundaramoorthy M., Neilson E.G. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N. Engl. J. Med. 2003; 348: 2543–2556
   PubMed Web of Science ®Google Scholar
• Kashtan C.E. The nongenetic diagnosis of thin basement nephropathy. Semin. Nephrol. 2005; 25: 159–162
   PubMed Web of Science ®Google Scholar
• Jalalah S.M., Alzahrani I.H., Furness P.N. Glomerular changes in microscopic haematuria, studied by quantitative immunoelectron microscopy and in situ zymography. Nephrol. Dial. Transplant. 2002; 17: 1586–1593
   PubMed Web of Science ®Google Scholar
• Nieuwhof C.M.G., de Heer F., de Leeuw P., van Breda Vriesman P.J.C. Thin GBM nephropathy: premature glomerular obsolescence is associated with hypertension and late onset renal failure. Kidney Int. 1997; 51: 1596–1601
   PubMed Web of Science ®Google Scholar
• Sue Y.M., Huang J.J., Hsieh R.Y., Chen F.F. Clinical features of thin basement membrane disease and associated glomerulopathies. Nephrology 2004; 9: 14–18
   PubMed Web of Science ®Google Scholar
• Nogueira M., Cartwright J. Jr., Horn K., Doe N., Shappell S., Barrios R., Coroneos E., Truong L.D. Thin basement membrane disease with heavy proteinuria or nephrotic syndrome at presentation. Am. J. Kidney. Dis. 2000; 35: E15
   Google Scholar
• van Paasen P., van Breda Vriesman P.J.C., van Rie H., Tervaert J.W.C. Signs and symptoms of thin basement membrane nephropathy: a prospective regional study on primary glomerular disease—The Limburg Renal Registry. Kidney Int. 2004; 66: 909–913
   PubMed Web of Science ®Google Scholar
• Haas M. Thin glomerular basement membrane nephropathy: incidence in 3471 consecutive renal biopsies examined by electron microscopy. Arch. Pathol. Lab. Med. 2006; 130: 699–706
   PubMed Web of Science ®Google Scholar
• Beirowski B., Weber M., Gross O. Chronic renal failure and shortened lifespan in Col4a3+/- mice: an animal model for thin basement membrane nephropathy. J. Am. Soc. Nephrol. 2006; 17: 1986–1994
   PubMed Web of Science ®Google Scholar
• Cosgrove D., Kalluri R., Miner J.H., Segal Y., Borza D.B. Choosing a mouse model to study the molecular pathobiology of Alport glomerulonephritis. Kidney Int. 2007; 71: 615–618
   PubMed Web of Science ®Google Scholar
• Tsukaguchi H., Sudhakar A., Le T.C., Nguyen T., Yao J., Schwimmer J.A., Schachter A.D., Poch E., Abreu P.F., Appel G.B., et al. NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J. Clin. Invest. 2002; 110: 1659–1666
   PubMed Web of Science ®Google Scholar
• Pereira A.C., Pereira A.B., Mota G.F., Cunha R.S., Herkenhoff F.L., Pollak M.R., Mill J.G., Krieger J.E. NPHS2 R229Q functional variant is associated with microalbuminuria in the general population. Kidney Int. 2004; 65: 1026–1030
   PubMed Web of Science ®Google Scholar
• Zenker M., Aigner T., Wendler O., Tralau T., Muntefering H., Fenski R., Pitz S., Schumacher V., Royer-Pokora B., Wuhl E., et al. Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum. Mol. Genet. 2004; 13: 2625–2632
   PubMed Web of Science ®Google Scholar
• Jarad G., Cunningham J., Shaw A.S., Miner J.H. Proteinuria precedes podocyte abnormalities inLamb2-/- mice, implicating the glomerular basement membrane as an albumin barrier. J. Clin. Invest. 2006; 116: 2272–2279
   PubMed Web of Science ®Google Scholar
• Farquhar M.G. The glomerular basement membrane: not gone, just forgotten. J. Clin. Invest. 2006; 116: 2090–2093
   PubMedGoogle Scholar
• Perry J., Tam S., Zheng K., Sado Y., Dobson H., Jefferson B., Jacobs R., Thorner P.S. Type IV collagen induces podocytic features in bone marrow stromal stem cells in vitro. J. Am. Soc. Nephrol. 2006; 17: 66–76
   PubMed Web of Science ®Google Scholar
• Harvey S.J., Zheng K., Sado Y., Naito I., Ninomiya Y., Jacobs R.M., Hudson B.G., Thorner P.S. Role of distinct type IV collagen networks in glomerular development and function. Kidney Int. 1998; 54: 1857–1866
   PubMed Web of Science ®Google Scholar
• Kashtan C.E. The wages of thin. J. Am. Soc. Nephrol. 2007; 18: 2800–2802
   PubMed Web of Science ®Google Scholar